New patent for Astrazeneca Pharms drug LYNPARZA

Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca Pharms and is included in two NDAs. It is available from one supplier. There are seven patents… The post New patent for Astrazeneca Pharms drug LYNPARZA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: